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Abstract: 
In eukaryotic translation initiation, eIF2⋅GTP/Met- tRNAiMet ternary 
complex (TC) interacts with eIF3/eIF1/eIF5 complex to form the multifactor 
complex (MFC), while eIF2·GDP associates with eIF2B for guanine nucleotide 
exchange. Gcn2p phosphorylates eIF2 to inhibit eIF2B. Here we evaluate the 
abundance of eIFs and their pre-initiation intermediate complexes in gcn2 
deletion mutant grown under different conditions. We show that ribosomes 
are three times as abundant as eIF1, eIF2 and eIF5, while eIF3 is half as 
abundant as the latter three and hence, the limiting component in MFC 
formation. By quantitative immunoprecipitation, we estimate that ∼15% of 
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the cellular eIF2 is found in TC during rapid growth in a complex rich medium. 
Most of the TC is found in MFC, and important, ∼40% of the total eIF2 is 
associated with eIF5 but lacks tRNAiMet. When the gcn2Δ mutant grows less 
rapidly in a defined complete medium, TC abundance increases 3-fold without 
altering the abundance of each individual factor. Interestingly, the TC 
increase is suppressed by eIF5 overexpression and Gcn2p expression. Thus, 
eIF2B-catalyzed TC formation appears to be fine-tuned by eIF2 
phosphorylation and the novel eIF2/eIF5 complex lacking tRNAiMet. 
Abbreviations used: 
eIF, eukaryotic initiation factor; TC, ternary complex; GAP, GTPase activating protein; G 
protein, guanine nucleotide binding protein; GEF, guanine nucleotide exchange factor; 
CTD, carboxyl-terminal domain; NTD, amino-terminal domain; YPD, yeast-extract 
peptone dextrose (medium); SC, synthetic defined complete (medium); MFC, 
multifactor complex; AA-box, acidic and aromatic amino acid box; PBS, phosphate-
buffered saline; GST, glutathione S-transferase; FH, FLAG-epitope and polyhistidine 
double affinity tag; WCE, whole cell extract 
Keywords: yeast, eIF, proteomics, nutritional control, translation initiation protein 
complex. 
Introduction 
The translation initiation reaction in eukaryotes starts with the 
dissociation of 80S ribosome into small 40S and large 60S ribosomal 
subunits, mediated by eukaryotic initiation factors (eIF) 1A and 3. The 
sequential binding of the eIF2⋅GTP/Met- tRNAiMet ternary complex (TC) 
and eIF4F/m7G-capped mRNA complex to the 40S subunit constitutes 
formation of the 43S and 48S preinitiation complexes, respectively. 
The multisubunit factor eIF3, eIF5 and eIF1 promote these assembly 
processes by binding directly or indirectly to the 40S subunit forming 
the 48S preinitiation complex (for reviews, see 1; 2). The 48S complex 
searches for the first AUG codon in the mRNA with the help of eIF1, 
eIF1A, the RNA helicase eIF4A and its cofactor eIF4B. Correct base 
pairing between the Met- tRNAiMet anticodon and the AUG codon 
triggers the hydrolysis of GTP bound to eIF2. This is stimulated by a 
GTPase activating protein eIF5 3 and the resulting phosphate release 
is coupled to eIF1 dissociation 4. These events lead to dissociation of 
eIF2·GDP and other pre-assembled eIFs, making it possible for the 
40S initiation complex to join with the 60S subunit, through the action 
of a second guanine nucleotide binding (G) protein eIF5B. Polypeptide 
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chain elongation starts from the methionine linked to the 80S initiation 
complex. Because only the GTP-form of eIF2 is capable of binding Met- 
tRNAiMet to form TC, GDP-bound eIF2 must be recycled to replenish 
eIF2·GTP by the guanine nucleotide exchange factor (GEF) eIF2B1; 2. 
The reactions described above are mediated by a series of 
complex assembly processes. eIF2 TC interacts with eIF1, eIF3 and 
eIF5 to form the stoichiometric multifactor complex (MFC) 5. The C-
terminal HEAT domain of eIF5, with the conserved acidic and aromatic 
amino acid (AA)-boxes 6; 7, serves as an important core of MFC by 
binding concurrently to eIF1 and the N-terminal domains (NTDs) of 
eIF2β and eIF3c (Reviewed in 2). The tif5-7A mutation altering the 
eIF5 AA-box 2 disrupts the interaction between eIF2 and eIF3 and 
confers temperature-sensitivity to yeast cell growth. This phenotype is 
suppressible by the co-overexpression of all three eIF2 subunits and 
tRNAiMet 5; 8. These results demonstrate that the eIF5-CTD stabilizes a 
critical bridge between eIF2 and eIF3, the two major components of 
43S pre-initiation complex. 
The interaction between eIF2·GDP and its nucleotide exchange 
factor eIF2B is also complex;eIF2B is made of five subunits with stable 
binding sites for the α and β subunits of eIF2, located at eIF2Bα/β/δ 
regulator subcomplex 9 and the C-terminal end of the minimal 
catalytic eIF2Bε-CTD segment 10, respectively. In addition, the 
eIF2Bε-CTD segment interacts with eIF2γ 11. The complexity of 
subunit interactions is in part due to the requirement for translational 
control mediated by eIF2 phosphorylation. From yeast to humans, 
eIF2 phosphorylation converts eIF2 from a substrate into a competitive 
inhibitor of eIF2B, thereby decreasing TC abundance. This effect 
inhibits general translation and paradoxically induces translation of 
GCN4 (in yeast) and ATF4 (in mammals) mRNAs encoding 
transcription factors by a mechanism involving upstream ORFs 
(uORFs) present in the 5′ leader region of each mRNA 12. Third, 
mRNA circularization is mediated through eIF4E bound to the 5′ cap 
and the poly(A) binding protein (PABP) bound to the poly(A) tail. 
eIF4E, PABP, and eIF4A all bind to the eIF4G subunit of eIF4F and 
enhances recruitment of the 40S subunit 13. 
 Proteomic approaches using yeast S. cerevisiae as a model 
eukaryote have generated numerous sets of data concerning protein 
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abundance and protein-protein interactions. In a founding study by 
Futcher et al., 2D gel electrophoresis was used to separate ∼1200 
different yeast proteins, of which 148 were identified by mass 
spectrometry. This study determined that the amounts of a large 
ribosomal protein Rpp0, eIF3b, and eIF4A are 277 × 103, 12 × 103, 
and 233 × 103 copies per cell, respectively 14. In a more 
comprehensive study, Ghaemmaghami et al. fused 98% of the 6234 
gene products in yeast with a C-terminal TAP sequence and measured 
the level of the fusions by anti-CBP antibodies 15. Their study 
indicated relative cellular abundances of 19 separate eIF polypeptides. 
In a further independent study, the McCarthy group measured the 
amount of eIF- 1, 1A, 2α, 2γ, 2Bα, 3g, 4A, 4B, 4E, and 4G1 in yeast 
whole cell extract (WCE) by immunoblotting with polyclonal antibodies 
raised against each protein and by using purified proteins as standards 
16. The comparison of the data obtained from the latter two studies 
showed a wide variation in eIF abundance estimates. In addition, the 
available yeast proteome data is unlinked to ribosome levels, except 
via the data from Futcher et al.14. This is partly because in 
Ghaemmaghami's approach, the C-terminal tagging of most ribosomal 
proteins was lethal. Furthermore, tRNAiMet abundance has not been 
determined in direct comparison with eIFs. 
  Another goal of proteomics is to study interactions between all 
the proteins in the proteome. Large-scale approaches have used 
systematic two-hybrid and protein array interaction assays 17 as well 
as mass-spectrometrical identification of proteins associated with 
affinity-purified TAP-tagged proteins 18; 19. A challenge in these 
approaches is to know how protein phosphorylation or ligand-binding 
regulates the formation and composition of different complexes 20; 
21. The translation initiation pathway involves several well-defined 
protein complexes whose formation is controlled by phosphorylation, 
bound nucleotides or RNA components. Without precise abundance 
information for co-purifying partners present in multiple complexes, it 
is difficult to partition proportions of each factor into each of the 
complexes formed. Thus in this study, we have extended the 
proteomics data relevant to translation initiation and determined the 
abundances of eIF complexes with a quantitative immunoprecipitation 
method. For this work, we have focused on the TC made of eIF2, GTP 
and Met- tRNAiMet and the MFC containing eIF1, eIF3, eIF5, and TC. We 
found that only a portion of eIF2/eIF5 complexes is a part of MFC, 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
6 
 
while the majority of the rest are not bound to Met- tRNAiMet. We 
established a method to measure cellular TC abundance and observed 
that dynamic changes in its steady-state levels are associated with 
growth medium composition and Gcn2p expression. Our results extend 
the recently proposed role for the eIF2/eIF5 complex lacking Met- 
tRNAiMet  in antagonizing the eIF2B activity 22, and suggest that 
alternative ways to control eIF2 TC abundance exist. 
Results 
The cellular level of eIFs in Saccharomyces cerevisiae 
We compared the eIF levels determined previously by the 
whole-genome TAP-tagging approach of Ghaemmaghami et al. 15, as 
well as the levels determined by von der Haar et al. using 
immunoblotting of cell extracts with polypeptide-specific polyclonal 
antibodies and purified eIF samples as standards 16 (Table I, columns 
3 and 4). These comparisons revealed both that large variations were 
apparent in the estimated abundances of the factors assessed and that 
neither dataset was comprehensive. We therefore decided to re-
evaluate the cellular abundance of various factors and extend the 
analysis to include additional factors, initiator tRNA and ribosomal 
protein levels not included in the previous studies. For this purpose, 
we employed a series of yeast strains encoding FLAG- or HA-epitope 
tagged versions of eIFs- 1, 2β 2Bγ, 3c, 3i, 4G1, 4G2, 5 or the large 
ribosomal protein Rpl25p as the sole source of these factors. These 
strains are listed in Table II. After the early exponential growth (to 
A600=1.5-2.0) in the nutrient-rich medium YPD, WCEs prepared by a 
mild glass beads disruption were used for immunoblotting. This 
method of WCE preparation is routinely used to analyze protein-
protein interactions (see below) and, with a minor modification, to 
produce a cell-free translation system 23. 
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Table I Comparison of eIF levels determined in this study with those 
reported by Ghaemmaghami et al. 15 and Von der Haar et al. 16 
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Table II Yeast S. cerevisiae strains employed for eIF and complex level 
determination 
As shown in Fig. 1A and B, fixed amounts of WCE from each 
strain were separated by SDS-PAGE and subjected to immunoblotting 
with anti-FLAG or anti-HA antibodies. The densities of FLAG-tagged eIF 
bands were quantified using NIH Image software, and presented as 
values relative to the level of eIF5-FL in row 1 of the tables below the 
immunoblotting patterns in Fig. 1A. Likewise, the densities of HA-
tagged eIF bands were quantified and presented as values relative to 
the level of eIF3i-3HA (row 1 of the table in Fig. 1B). To normalize for 
any effects of epitope-tagging on the expression level of each eIF, we 
probed the same membrane as used for anti-FLAG or –HA with 
antibodies raised against the relevant unmodified protein (see Fig. S1 
for a representative example) and found that the presence of the tag 
did not affect protein abundance (row 2 of the tables in Fig. 1A-B) for 
all proteins assessed except for FL-eIF1 that was expressed from a 
stronger GPD promoter to increase its detection (see below; all other 
tagged eIFs were expressed from the natural promoter except for HA-
eIF4G1 in YAS2136. HA-eIF4G1 in this strain is expressed under the 
TIF4632 promoter, but we confirmed that its abundance is identical to 
that of untagged eIF4G1 in the other strains). Note that the strains 
expressing each tagged allele have different genetic backgrounds 
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(Table II). This indicates that differences between strains in commonly 
used genetic markers and the presence or absence of GCN2 in 
particular, does not affect eIF protein abundance. Because amino acid 
composition of the measured protein may change its transfer efficiency 
to the blotting membrane (see Fig. 2), we then normalized the 
abundance values for the immuno-detection efficiency (row 3 of the 
table in Fig. 1A-B). After these normalizations, the cellular levels of 
eIFs and Rpl25p, relative to that of eIF5, were determined and these 
values are summarized in the bottom row of the tables in Fig. 1A and 
B. 
 
Fig. 1 Determination of cellular eIF levels. 
(A) Example of quantitative detection of indicated FLAG-tagged proteins in WCE from 
yeast strains by immunoblotting with anti-FLAG antibodies. Table summarizes 
densitometry analysis to determine the expression level relative to eIF5 (set to 
100%). FLAG antibody signal density was controlled by the following two factors: (1) 
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Relative expression level of the epitope-tagged protein, compared to the endogenous 
level of the cognate protein. This was determined by immunoblotting with antibodies 
raised against each protein (see Fig. S1). (2) Relative detection efficiency of the FLAG-
tagged protein, compared to that of eIF5-FL, as determined by anti-FLAG antibodies. 
(See Fig. 2 below). N. T., not tested due to technical problems or lack of antibodies. 
(B) Determination of HA-tagged eIF levels. Analysis was done as in panel A but with 
indicated HA-tagged yeast strains and anti-HA antibodies. (C) Data from Ref. 16 and 
Ref. 15 plotted against data from this study as empty squares and filled diamonds, 
respectively. Dotted arrows indicate values for individual eIFs. Grey line indicates the 
linear regression with the data from 16. For the data from 15, the eIF3 and eIF2 levels 
were averaged from the values for the a/b/c- and α/γ– subunits, respectively. The 
eIF2B level was averaged from the values for α, β, γ and δ subunits. 
 
Fig. 2 Transfer and detection efficiency of purified FLAG-eIFs. 
Indicated amounts of purified proteins were subjected to SDS-PAGE, followed by 
Coomassie Blue staining (panel A, lanes 1-10) or immunoblotting with anti-FLAG 
antibodies (panel A, lanes 11-27; panel B). To increase the accuracy of measuring the 
intensity of anti-FLAG detection per pmol of FLAG-proteins, we ran two separate SDS-
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PAGE gels at the same time, one loaded with indicated amounts of purified proteins, 
and the other loaded with four times more of the same proteins. The former was 
subjected to immunoblotting as shown, and the latter was stained with Coomassie 
Blue to determine the protein concentrations of the samples in comparison with the 
amount of eIF5-FL on the same gel. The eIF5-FL sample concentration was determined 
by comparing to known amounts of BSA, as shown in Panel A, lanes 2-5. The results 
indicate that the detection efficiency for all expect eIF1 (as in C) and eIF2Bγ is 
identical. That for eIF2γ is 2.0, because of two copies of the FLAG epitope. (C) The 
density of anti-FLAG reactivity was plotted against molar amounts of FL-eIF1 or eIF5-
FL in each lane. 
The relative expression value indicated for eIF1 deviated most 
from the original density value (table in Fig. 1A). This is because: (i) 
FL-eIF1 expression was increased by 4-fold compared to the 
endogenous eIF1 due to using a stronger GPD promoter (row 2) and 
(ii) FL-eIF1 was detected 24 times less effectively than eIF5-FL (Fig. 
1A, table row 3, and Fig. 2B-C). The second point was determined by 
anti-FLAG immunoblotting with known amounts of purified 
recombinant FL-eIF1 and eIF5-FL, as shown in Fig. 2B. In contrast, the 
efficiency of detection was indistinguishable between recombinant 
forms of FL-eIF2β, eIF3i-FL, Rpl25-FL, eIF5-FL and eIF2Bγ-2FL (the 
latter from eIF2B purified from yeast, Fig. 2A). Our data are in 
agreement with previous observations 15 that most yeast proteins 
visible by Coommassie Blue staining in SDS-PAGE are transferred to 
nylon or nitrocellulose membranes at nearly identical efficiency (data 
not shown). Thus, eIF1 is clearly an exception. We suspect that altered 
transfer or detection efficiencies for a minor subset of the proteome 
produce a limitation for systematically determining the levels of the 
proteins encoded in the genome. 
Because we obtained abundance values relative to total eIF5 
(Fig. 1A and B), we converted them into absolute copies per cell, by 
comparing our relative ribosome abundance of 298% of total eIF5 with 
the previously determined ribosome abundance of 200,000 copies per 
cell 24 (Fig. 1A). The calculated absolute abundance values are 
presented in Table I, column 5. To establish a limiting factor in TC 
formation, we also determined the cellular abundance of tRNAiMet and 
directly compared it with the cellular level of eIF2. For this purpose, 
we used known amounts of purified eIF2 and tRNAiMet as standards on 
Western and Northern blots and analyzed them side-by-side with the 
same from yeast WCE. We estimated that the level of tRNAiMet is ten 
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times higher (640,000 copies/cell) than that of eIF2 (63,000 
copies/cell), indicating that eIF2 is the limiting component in forming 
ternary complexes in vivo. 
Our data indicates that ribosomes are three times as abundant 
as the multi-factor complex (MFC) components eIF1, eIF2 and eIF5 
(81,000, 63,000, and 67,000 copies/cell, respectively; Table I, column 
5). eIF3 (32,000-34,000 copies/cell) is present at half the levels of 
other MFC components; thus, eIF3 is the limiting component in the 
formation of MFC. Met- tRNAiMet is in large excess over eIF2 (provided 
that a significant proportion of tRNAiMet is aminoacylated; see below 
Fig. 3C), whereas eIF2B (5000 copies/cell) is the least abundant factor 
we measured. eIF2Bγ is present at only ∼7% of the level of eIF2. 
These observations agree with the idea that GTP binding to eIF2 is the 
limiting step in forming TC. When plotted against the values obtained 
by von der Haar et al. 16, our data of eIF abundance have almost a 
linear correlation with theirs, with the slope of the linear regression 
being 2.94 (Fig. 1C). We do not know why the values from von der 
Haar et al. are three times higher than those we obtained in this study 
(Table I, columns 4 and 5). We note, however, that the authors did 
not measure ribosome or ribosomal protein abundance by their 
methods, so their values are in theory unlinked to the ribosome level, 
a commonly used standard. In conclusion, our data largely confirmed 
the relative (but not the absolute) abundance values determined by 
von der Haar et al.16, and importantly, add new information about the 
level of eIF5 and (Met-) tRNAiMet, and the relationship between 
individual initiation factor abundance and ribosome abundance (see 
below Fig. 7). 
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Fig. 3 Determination of TC and eIF assembly intermediate levels in vivo and 
identification of a novel eIF2/eIF5 complex lacking tRNAiMet. 
(A) 1 mg of WCE prepared from KAY17 (Control), KAY128 (TIF5), and KAY284 (tif5-
7A) was used for anti-FLAG immunoprecipitation, and 80 % (top gel) and 20 % 
(bottom gels) of the precipitated fractions (lanes under IP) were analyzed by northern 
and western blotting, respectively, with 2% in-put amount (lanes under In-put) and 
purified tRNAiMet and eIF2 as the standard (not shown), as described under Materials 
and Methods. The molar amounts (per 1 mg WCE) of precipitated components, 
calculated in comparison with the band densities of purified components, are listed 
below each panel. (B) TC and MFC levels. % of tRNAiMet - or eIF3-bound eIF2 
compared to total eIF2, observed in KAY128 (WT) and KAY284 (7A), is shown by bars 
with SD in lines. (C) Confirmation of intact Met- tRNAiMet during TC level 
determination. Our prep; the RNA samples were isolated from the in-put WCE sample 
under acidic conditions and analyzed by the acidic urea PAGE and the detection using 
a probe for tRNAiMet, all as described under Materials and Methods. Control; intact 
aminoacyl tRNA sample was prepared directly from yeast and analyzed similarly. +; 
fully deacylated by incubating in 2 M Tris-HCl (pH 8.0) at 37°C, 30 min. -; no alkaline 
treatment. (D) and (E) Analyses of eIF complexes by sucrose gradient-velocity 
sedimentation. KAY25 (FL-SUI3) was grown in YPD at 30°C, treated with 
cycloheximide for 5 min, and then harvested for preparation of WCE, as described 
previously 54. 25 A260 units of the WCE were fractionated on 5-45% sucrose gradients 
by centrifugation at 39000 rpm for 2 h. (D) Top panel, A254 profile indicating the 
positions of ribosomal species. A half of the first 5 fractions was precipitated with 
ethanol and analyzed by SDS-PAGE and immunoblotting with antibodies indicated to 
the right. (E) The reminder of the fractions was incubated with anti-FLAG affinity resin 
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(Sigma) for 30 min, followed by washing 4 times. eIFs in ethanol- or immuno-
precipitated fractions were analyzed for immunoblotting together on the same gel, to 
know the relative amount of FL-eIF2 precipitated. In, 1% of the input amount. 
 
Fig. 7 The abundance model of eIF2 assembly reactions in S. cerevisiae 
cells growing in the YPD medium. 
The right column describes a sequence of eIF2 reactions from the previous round of 
initiation (Initiation) to the formation of 43S complex (MFC ≃ 43S) for the new round 
of initiation. The levels of eIF2 intermediate complexes determined in this study were 
translated into absolute levels, based on the ribosomal level of 200 000 copies/cell 24 
and presented in italicized beside the relevant complexes. The following values were 
used for calculation: Total eIF2 level, 63,000 copies/cell. Total eIF2/eIF5 complex, TC 
and MFC level, 54%, 15%, and 7.5% of total eIF2, respectively (from Fig. 3A, Fig. 5A 
and other independent experiments). Total TC/eIF5 complex level, 22% of eIF2 bound 
to eIF5 (from Fig. 5D and other independent experiments). The left column depicts the 
dissociation of the ribosome. The level (italicized) and percentage (in parentheses) of 
the ribosome in each stage are presented. Although we reason that the eIF2/eIF5 
complex lacking tRNAiMet is bound to GDP, this needs to be demonstrated in the future. 
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Determination of eIF2 TC and MFC levels in vivo 
Having established abundances of individual factors, we wished 
to determine what proportions were present in different complexes 
that form pre-initation factor complex intermediates. To determine TC 
level, we immunoprecipitated FL-eIF2 from a gcn2Δ strain KAY128 
encoding FL-eIF2β as the sole source of eIF2β and determined the 
amount of eIF2 and coprecipitating tRNAiMet by Western and Northern 
blotting, respectively. Known amounts of each purified component 
were included as standards (not shown in Fig. 3A). Analysis of 
supernatant fractions revealed that there is nearly a full recovery of 
FL-eIF2 in the pellet fractions, suggesting that FL-eIF2 complexes are 
stable during the course of these experiments (data not shown). Fig. 
3A shows that 2.5 pmol FL-eIF2 coprecipitated with 0.42 pmol of 
tRNAiMet, indicating that only 16% of eIF2 is tightly associated with 
tRNAiMet. This is likely to be in the form of the ternary complex (TC). 
From this and several other independent experiments, we conclude 
that the cellular TC level represents 13.4% ± 2% of the total cellular 
eIF2 (Fig. 3B, column 1). 
These data also indicate that the amounts of eIF3 (0.3 pmol), 
eIF1 (0.4 pmol) and tRNAiMet (0.42 pmol) that coprecipitating with FL-
eIF2 are roughly equivalent (Fig. 3A), suggesting that tRNAiMet binding 
to FL-eIF2 occurs in the context of the multifactor complex under 
these growth conditions. Because interaction between eIF2 and eIF3 
depends on an intact eIF5 C-terminal domain (CTD) 5; 25, the 
presence of eIF3 in complex with eIF2 is the hallmark of MFC (Fig. 3A, 
fourth panel). Fig. 3B shows that the level of MFC, determined by the 
ratio of precipitated eIF3 to eIF2, is 7.6 ± 2% of total eIF2. Together 
with the cellular TC levels calculated above, these results suggest that 
once TC is formed it is rapidly converted into MFC. 
The methionyl moiety of Met- tRNAiMet directly binds eIF2γ and 
this interaction promotes TC formation 2. Thus, deacylation of Met- 
tRNAiMet during WCE preparation could potentially decrease its affinity 
for eIF2, and hence reduce the yield of tRNAiMet t in the FL-eIF2 
complex. To assess if this was a problem with our assays, we analyzed 
the ratio of aminoacylated:deacylated tRNAiMet in our WCE preparations 
by extracting total RNA under acidic conditions, and by using acidic 
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urea PAGE to detect and quantify aminoacylated and deacylated forms 
of tRNAMeti26. As a control, we used aminoacyl-tRNA samples that 
were prepared under acidic conditions. Fig. 3C indicates that similar 
fractions (∼65%) of tRNAiMet molecules were aminoacylated in both our 
WCE preparation (lane 4) and intact aminoacyl tRNA sample (lane 2) 
and that Met- tRNAiMet molecules in both the samples were deacylated 
completely after treatment with a basic buffer (pH 8.0) (lanes 1 and 
3), as previously observed 26. Therefore Met- tRNAiMet deacylation was 
not occurring in our cell extracts and would not bias our measurement 
of TC abundance. 
To exclude the possibility that TC free of MFC easily dissociates 
tRNAiMet during the immunoprecipitation reaction, we determined TC 
levels in the tif5-7A mutant, which alters the eIF5 AA-box 2 and is 
known to disrupt MFC formation 8. As mentioned earlier, tif5-7A is a 
seven-alanine substitution that likely unfolds C-terminal HEAT-repeat 
α-helices of the CTD structure. Fig. 3A, lane 6, shows that this 
mutation only partially reduced tRNAMeti co-precipitation from 15 % 
to 11% (boxed below second gel, Fig. 3A) compared to FL-eIF2 
precipitated (see Fig. 3B for quantification). In contrast, the mutation 
substantially reduced the amount of eIF3b precipitated (Fig. 3A-B), 
confirming disruption of MFC. Thus, though apparently small, the TC 
level determined in Fig. 3 is likely an authentic value. 
∼40% of eIF2 complexes with eIF5 but lacks Met- 
tRNAiMet in vivo 
Fig. 3A also indicates that a significantly higher proportion of 
eIF2 is associated with eIF5 (1.4 pmol out of 2.5 pmol FL-eIF2 
precipitated) than the proportion of eIF2 bound to tRNAiMet (0.42 
pmol). This and several other experiments indicated that 54 ± 9 % of 
eIF2 is associated with eIF5. Given that TC level is ∼15 % of total eIF2 
and that MFC level is smaller than this value, the data implies that 
∼40% of eIF2 is present in a binary complex with eIF5 devoid of 
tRNAiMet. This was a surprising finding that promoted further 
experimentation. To confirm this with a different strain but with the 
same technique, we performed a quantitative immunoprecipitation 
using yeast strain KAY35 encoding eIF5-FL. We confirmed that ∼60% 
of eIF5-FL was associated with eIF2. Of eIF2 that co-precipitated with 
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eIF5-FL, only 22 ± 5 % (n = 7) was bound to tRNAiMet (see Fig. 5C, 
lane 5, below for a typical example). Thus, the unexpected finding of 
eIF5/eIF2 complex lacking tRNAiMet was confirmed in the two 
independent assays and likely not an artifact caused by the position of 
the tag introduced. 
 
Fig. 5 Comparison of the abundance of eIF2- and eIF5-containing 
complexes between cells grown in YPD and SC media. 
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(A) Strain KAY128 (FL-SUI3 gcn2Δ; sc eIF5) and its isogenic hc eIF5 derivative 
KAY482 (hc eIF5), together with a control strain KAY113 carrying an unmodified SUI3 
(C), were grown in YPD (Y) or SC (S) medium and subjected to quantitative 
immunoprecipitation, as in Fig. 3A. Immuno-precipitated fractions were analyzed by 
Nothern blotting for tRNAiMet (top gel) and immunoblotting for eIF2α (second gel), eIF5 
(third gel) and eIF1 (fourth gel) (lanes 6-10), together with 2% of in-put amount 
(lanes 1-5). Amount of precipitated proteins per 1 mg WCE is presented below each 
gel in pmol. Bottom gel indicates the position and amount of EtBr-stained 5.8S and 5S 
rRNA and total tRNA from the same acrylamide gel prior to transfer to a membrane 
and Northern hybridization. Note that some tRNA non-specifically coprecipitated with 
the 43S particle in lanes 7-10 and obscured specific tRNAiMet precipitation when 
examined by EtBr staining alone. (B) The abundance of TC, MFC (left) and total 
eIF2/eIF5 complex (right) was quantified from (A) and at least three other 
independent experiments as ratio of co-precipitated tRNAiMet, eIF1 and eIF5, 
respectively, to total eIF2. (C) Strain KAY35 (gcn2Δ TIF5-FL) and a control strain 
KAY113 (C) carrying an unmodified TIF5 were grown in YPD (Y) or SC (S) medium and 
subjected to quantitative immunoprecipitation and the results presented exactly as in 
Fig. 3A and and4A4A. 
To verify the occurrence of a ribosome-free eIF2/eIF5 binary 
complex, we resolved the eIF complexes in cell extracts using sucrose 
gradient-velocity sedimentation. In these experiments, cycloheximide 
was employed to preserve intact ribosomal complexes. As shown in 
Fig. 3D, the strain encoding FL-eIF2β contains substantial amounts of 
eIF2 and eIF5 in the ribosome-free fractions 1-2. Anti-FLAG 
immunoprecipitation of gradient fractions indicates that the majority of 
FL-eIF2 precipitated in fractions 1-2 is associated with eIF5 (Fig. 3E, 
lanes 1-2). We recently reported a similar gradient analysis using a 
strain encoding eIF5-FL and showed that eIF5-FL present in the top, 
ribosome-free fractions also co-precipitated with eIF2 and, moreover, 
lacked tRNAMeti22. These reciprocal experiments establish the 
presence of the novel eIF2/eIF5 complex in the sucrose gradient. 
Together with further control experiments on our quantitative 
immunoprecipitation that were not reported previously 22, the results 
shown in Fig. 3 warrant the authenticity of the eIF complex abundance 
values presented in this study. 
The level of eIF2/eIF2B complex in vivo 
Next, we wished to determine the abundance of the eIF2/eIF2B 
complex. As shown in Fig. 3A, nearly all of eIF2B is associated with FL-
eIF2. The amount of eIF2/eIF2B complex accounts for 7% of eIF2 (see 
Fig. 7 for summary). In the sucrose gradient analysis, the majority of 
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eIF2B is present in fraction 3 preceding the 43S/48S complex fraction 
(Fig. 3D), indicating that the FL-eIF2/eIF2B complex is formed and 
migrates more slowly than the 40S ribosome. Furthermore, eIF2Bα 
and eIF2Bδ present in ribosome-free fraction 3 co-immunoprecipitated 
with anti-FLAG just as efficiently as FL-eIF2 (Fig. 3E), indicating that 
nearly all of eIF2B free from the 40S ribosome is associated with eIF2. 
These results are consistent with previous immunoprecipitation of 
eIF2B with anti-eIF2Bε antibodies, indicating that the nearly entire 
eIF2B co-immunoprecipitates with eIF2 and that the eIF2/eIF2B 
complex accounts for ∼10% of the total eIF2 27; 28. Thus, as an 
enzyme substoichiometric to its substrate, the majority of eIF2B 
appears to be fully engaged in the guanine nucleotide exchange 
reaction and, consequently, to bind eIF2·GDP or eIF2 alone, prior to 
GTP binding. Tight association between eIF2 and eIF2B has been noted 
since these factors were discovered in mammals and yeast 29. 
The interaction between eIF5 and eIF2 is not affected 
by GDP or GMPPNP in vitro 
The observation of the binary eIF2/eIF5 complex devoid of 
tRNAiMet (Fig. 3) suggests that eIF5 can bind eIF2 in vivo even when 
the latter is bound to GDP. This idea is consistent with the finding that 
eIF5 or its CTD (aa. 241-405) can bind the isolated eIF2β subunit in 
the absence of eIF2γ that binds GTP or GDP 8; 30. To test the effect of 
guanine nucleotides on the interaction between eIF5 and eIF2 directly, 
we allowed GST-eIF5 to bind purified eIF2 in the presence and 
absence of 1 mM GDP or GMPPNP, the nonhydrolyzable GTP analogue. 
[GMPPNP is used because commercially available GTP is contaminated 
with GDP, while GMPPNP is not. The major GMPPNP contaminant is 
GTP (∼2%) (Roche).] As shown in Fig. 4, GST-eIF5 or GST-eIF5 (241-
405) bound to eIF2 with an affinity of KD ∼100 nM in the absence or 
presence of the guanine nucleotide used. Thus, the eIF5/eIF2 
interaction is not inhibited by GDP nor is it stimulated by GMPPNP. 
During the course of this study, Algire et al. showed, without 
presenting data, that the affinity of eIF2 for eIF5 in vitro is not altered 
by nucleotide or Met-tRNAiMet 11 binding 4. Our results using GST-
eIF5-CTD and purified eIF2 also demonstrate that the high affinity of 
eIF2 for eIF5 is due to interaction mediated by eIF5-CTD but not due 
to its NTD directly involved in the GAP activity. Together, these results 
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confirm the finding reported by Algire et al. 4 and suggest that an 
eIF2·GDP/eIF5 complex can form, at least in vitro. 
 
Fig. 4 The effect of guanine nucleotides on GST-eIF5 binding to purified 
eIF2. 
Indicated amounts of GST-fusion forms of full-length eIF5 (A, C) or its CTD (aa. 241-
405) (B) were allowed to bind 20 ng of purified eIF2 in the presence of 1 mM guanine 
nucleotides, indicated across the top, and the complex formed was analyzed by GST 
pull down, as described previously 51. Bound eIF2 was visualized by immunoblotting 
(bottom panels), whereas GST-eIF5 proteins pulled down was visualized by Ponceu S 
staining (top panel). Graph to the right shows % of eIF2 bound to GST-fusion proteins 
(in panel A and C, average values for eIF2α and eIF2γ bound) plotted against the 
concentration of the latter. 
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The effect of nutrient change on the abundance of eIFs, 
ribosomes, and eIF complexes 
The amounts of eIFs and their complexes, as determined in 
Figs. 1 and and3,3, were measured with the yeast gcn2Δ strain 
KAY128 (Table II) growing exponentially in a complex (undefined) rich 
medium YPD (see Materials and Methods) at the doubling time of 1.5 
hr. In the synthetic defined medium supplemented with amino acids 
(SC), the same cells grew at the doubling time of 2.1 hr. Immunoblot 
analyses of WCE prepared from cells grown in YPD and SC media 
indicated no significant change in the levels of eIF1, all three eIF2 
subunits, all five eIF2B subunits, a, b, g and i subunits of eIF3, eIF5, 
and eIF4G1 (data not shown). Sucrose gradient analyses of ribosomes 
present in the WCE preparation (not shown) and electrophoretic 
analysis of rRNAs isolated from the same preparation (Fig. 5A, bottom 
gel, lanes 2-3, for 5S and 5.8S rRNAs) indicated no discernable change 
in total ribosome abundance. Interestingly, quantitative 
immunoprecipitations revealed that the fraction of FL-eIF2 associated 
with Met- tRNAiMet is significantly higher in the SC medium than in the 
YPD medium (Fig. 5A, first and second gels). Averaged data from 
several independent experiments indicated that the TC abundance was 
3 times higher in cells grown in SC medium than in the same cells 
grown in YPD medium (Fig. 5B). 
We found that the MFC abundance was, on average, unaltered 
between cells grown in the YPD versus the SC medium, when 
measured by the amount of FL-eIF2 associated with eIF1, one of the 
critical MFC components (Fig. 5A, fourth gel, and B). Moreover, the 
total abundance of the eIF2/eIF5 complex was not altered (Fig. 5A, 
third gel, and B). Because the TC level increased in the SC medium, it 
was conceivable that the abundance of a complex between eIF5 and 
TC, but lacking other MFC partners was also increased. However, the 
amount of tRNAiMet associated with eIF5-FL in a TIF5-FL strain only 
marginally increased (by 10±2 %) in the defined SC medium 
compared to the complex levels observed in YPD medium (Fig. 5C). 
Analysis of eIF1 and eIF3b co-precipitated with eIF5-FL indicated that 
the amount of eIF1 bound to eIF5-FL dramatically increased while the 
level of eIF5-FL-bound eIF3b did not change (Fig. 5C, third and fourth 
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gels). Notably, one third of eIF5-FL is bound to eIF3 in both the 
conditions (Fig. 5C, fourth gel). Given that the abundance of eIF3 is 
about half of that of eIF5 (Fig. 1 and Table I), the majority (two thirds) 
of eIF3 is associated with eIF5 regardless of the growth conditions. In 
this context, the significant increase in eIF1 associated with eIF5-FL 
observed in the SC medium indicates that nearly all of the eIF3/eIF5 
complexes bind eIF1 when the cells are grown in the SC medium. In 
conclusion, growth in SC medium significantly increases the 
abundance of both TC and eIF1/eIF3/eIF5 complexes, demonstrating 
that dynamic changes in eIF intermediate complexes can result from 
changes in nutrient availability and/or growth rate. It is noteworthy 
that these changes were observed in a gcn2Δ background. Thus, they 
are independent of eIF2 phosphorylation and therefore are likely 
dependent on other nutrient-sensing pathways (see Discussion). 
The effect of Gcn2p expression on the cellular TC level 
Gcn2p is known to partially phosphorylate eIF2 when cells are 
grown in synthetic defined media 31; 32. Because eIF2 
phosphorylation inhibits eIF2B and thereby reduces TC level, Gcn2p 
expression in SC medium is expected to lower TC abundance. As 
shown in Fig. 6A, we indeed found that Gcn2p expressed from the 
p722 plasmid lowered TC level in the strain KAY128 grown in SC 
medium (compare lanes 5 and 6). The TC abundance in the presence 
of Gcn2p was reduced on average from 50% to 25% compared to total 
eIF2 in this medium (Fig. 6B). As a control, eIF2 abundance was not 
altered by p722 (data not shown). These results confirm that the 
Gcn2p kinase plays a role in downregulating TC abundance in the SC 
medium. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
23 
 
 
Fig. 6 Gcn2p expression down-regulates TC formation in the SC medium. 
(A) Quantitative immunoprecipitation was performed using KAY128 (gcn2Δ FL-SUI3) 
transformants carrying an empty vector (gcn2Δ) and p722 (GCN2) and a control 
KAY113 (gcn2Δ SUI3) transformant carrying an empty vector, exactly as in Fig. 3A. 
The cells were grown in SC-ura medium. (B) TC levels measured from panel (A) and 
three other independent experiments with SD in lines. 
The eIF2/eIF5 complex downregulates TC formation 
Next, we wished to understand the mechanism by which the 
growth in the SC medium derepresses TC abundance in the gcn2Δ 
strain. One mechanism, suggested by the increase in the level of 
eIF1/eIF3/eIF5 complex (Fig. 5C), postulates that the growth in the SC 
medium decreases the rate of translation initiation by the ribosome 
preinitiation complex without inhibiting eIF2B activity and TC 
formation. Reducing the rate of a later step in the initiation pathway 
could achieve this and would result in increase in the level of TC and 
the eIF1/eIF3/eIF5 complex, both awaiting consumption by actively 
initiating ribosomes. An alternative but mutually consistent model 
came from our discovery of the eIF2/eIF5 complex free of tRNAiMet and 
genetic evidence suggesting that this complex antagonizes TC 
formation catalyzed by eIF2B 22. Although we did not observe the 
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change in the abundance of the eIF2/eIF5 complex between the two 
media tested, the possible modification of the complex by other 
signaling pathways was not excluded. To test whether the alteration in 
the stability of the eIF2/eIF5 complex is responsible for the high TC 
abundance in SC medium in the absence of Gcn2p, we measured TC 
levels in the isogenic gcn2Δ strain KAY482 overexpressing eIF5 from a 
high-copy (hc) plasmid. hc eIF5 would likely increase the eIF2/eIF5 
complex stability by mass action. As expected, hc eIF5 substantially 
lowered the TC level in the SC medium with concomitant increase in 
the amount of eIF2/eIF5 complex (Fig. 5A and B). These results 
support (though do not prove) the model that the novel eIF2/eIF5 
complex controls the eIF2B activity to maintain the TC abundance at a 
low level. However, because we have not observed any change or 
modification made to the eIF2/eIF5 complex, we cannot exclude the 
possibility that the suppression observed with hc eIF5 is a bypass of 
the normal pathway not involving the regulation of the eIF2/eIF5 
complex (see Discussion). 
The deduced levels of ribosomal preinitiation complexes 
While our methods of cell lysis and immunoprecipitation did not 
permit us to examine the ribosomal preinitiation complex levels 
directly, our data are largely consistent with the known proportions of 
dissociated ribosomal subunits and the level of 43S complex 
components. The abundance model summarized in Fig. 7 for yeast 
grown in the YPD medium includes the levels of different ribosomal 
species (italicized) and their percentage compared to total ribosome 
(in parenthesis). We estimate that 7.5% of total eIF2 is present as 
MFC (Fig. 3B). If all MFCs bind the dissociated 40S subunit to produce 
the 43S complex, ∼2.4% (4700 copies/cell; based on the ribosomal 
level of 200,000 copies/cell) of 40S subunits will be found as 43S 
complexes. In our polysome profile experiments (such as shown in Fig. 
3D, top panel), we consistently observed that ∼10% of ribosomal 
subunits are dissociated during yeast grown in the YPD medium (data 
not shown). Thus, up to a quarter of dissociated 40S subunits 
participate in the 43S complex. It is conceivable that the 40S subunits 
free from MFC contain eIF3 alone or its complex with eIF1 and/or eIF5, 
depending on their affinity for the ribosome. Indeed, eIF3 abundance 
is ∼16% of total ribosome (Table I), consistent with the idea that eIF3 
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associates with MFC components off the ribosome in addition to 
participating in 43S complex formation. Although we did not measure 
eIF1A abundance, von der Haar et al. estimated it at 28% of total eIF2 
(Table I, column 4) 16, or ∼9% of total ribosome by our standards (i. 
e., eIF2 abundance as one third of ribosome abundance), consistent 
with the idea that the majority of eIF1A is bound to dissociated 40S 
subunits to set the stage for 43S complex formation and subsequently 
regulate 48S complex function 33. 
Discussion 
Cellular abundance of translation initiation components 
and their complexes in S. cerevisiae 
In our evaluation of cellular eIF, tRNAiMet and ribosome levels, 
we not only confirmed and refined the cellular abundance of individual 
eIFs, but also determined the ribosome and Met- tRNAiMet levels in 
direct comparison with them. The determined relationship between the 
ribosome and eIF levels allowed us to deduce the steady-state 
abundance of ribosomal preinitiation complexes (Fig. 7). 
During the course of this study, Newman et al. measured the 
fluorescence of 4159 GFP-tagged yeast strains 34. Protein fusion to a 
large tag like GFP generally changes the protein stability. In addition, 
protein complex formation might quench fluorescence from the GFP-
tag. Indeed, their GFP-eIF abundance values are in general >10 times 
lower than our values. The ribosomal protein levels were also 
measured for those encoded by two alleles in the genome. The 
average for 44 measured small ribosomal proteins (Rps) was 3619 ± 
2414 copies/cell, and that for 63 measured large ribosomal proteins 
(Rpl) 4329 ± 3406 copies/cell. Of these, Rpl8A and Rpl9B showed the 
highest abundance of 17952 and 20074 copies/cell, which are still 10 
times lower than the previously established ribosome level 24. 
Therefore it seems difficult to determine the absolute abundance of 
proteins based solely on a GFP-tagging approach. 
Our measurement of eIF2-containing complex abundance 
provides insight into the mechanism and control of translation 
initiation (Figs. 3, ,55 and and6).6). Our finding that TC and MFC 
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represent only ∼15% and ∼8% of total eIF2, respectively, in yeast 
actively growing in YPD medium (Fig. 3) supports the idea that TC 
formation is a rate-limiting step in translation initiation and that once 
formed, TC is rapidly converted into the MFC. However, this was not 
the case when yeast were grown less rapidly in SC medium (Fig. 5). 
The TC abundance increased 3-fold, while MFC levels were unaltered, 
consistent with the reduced growth rate. Thus, TC abundance appears 
to be carefully controlled in accordance with nutrient composition 
and/or growth rate. Here we investigated two possible mechanisms to 
explain these observations (Figs. 5 and and6);6); firstly a role for 
Gcn2p activation and secondly via a novel eIF5/eIF2 complex lacking 
tRNAiMet, as discussed next. 
Fine-tuning of TC abundance by Gcn2p and the novel 
eIF2/eIF5 complex 
Our finding that TC abundance in a gcn2Δ strain was increased 
by three fold in the synthetic defined complete (SC) medium (Fig. 5A) 
suggests that eukaryotes possess a mechanism(s) to finely tune the 
levels of this critical translation component. As the observed increase 
in TC was suppressed by GCN2 expression in the strain (Fig. 6A-B), 
the modest eIF2 phosphorylation that had been observed under similar 
growth conditions 31; 32 appears to contribute to maintaining a lower 
level of TC. Gcn2p is activated by binding of uncharged tRNA that 
accumulates during amino acid starvation 35. How Gcn2p is activated 
in the presence of abundant amino acids in the medium is unclear. It is 
possible that a limited supply of certain critical components regulates a 
second nutritional signaling pathway. One such nutrient sensing 
pathway known to regulate translation is the TOR kinase pathway 36. 
Consistent with this, the inhibition of TOR kinases is shown to activate 
Gcn2p in S. cerevisiae37. A second nutrient sensing pathway that 
regulates translation is the PAS kinase pathway 38. 
A second mechanism to modulate TC abundance was suggested 
from our observation that hc eIF5 reverses the TC increase observed 
in the absence of Gcn2p (Fig. 5A-B). Although hc eIF5 can perturb 
MFC formation by producing partially formed MFC, as proposed 
previously 8, this mechanism does not explain the observed decrease 
in TC (Fig. 5A-B). Rather, we suggest that hc eIF5 stabilized the 
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eIF2/eIF5 complex by mass action, which in turn inhibited eIF2B-
catalized eIF2·GDP recycling and hence TC formation. In our recent 
study, we provided ample genetic and biochemical evidence for this 
idea using (i) a eIF5-CTD mutation that specifically disrupts eIF2 
binding and restores TC decrease caused by hc eIF5 and (ii) eIF2Bε 
mutations whose phenotype resulting from reduced TC formation was 
exacerbated by hc eIF5 22. The latter results suggest that wild-type 
eIF2Bε (the catalytic subunit of eIF2B) is required for eIF2B to out-
compete the inhibition by eIF5 bound to its substrate eIF2·GDP, 
perhaps by displacing eIF5 from the eIF2/eIF5 complex. Thus, a 
second mechanism to maintain the TC abundance homeostasis might 
indeed operate via the novel eIF2/eIF5 complex. 
In an effort to understand the direct effect of nutrient shift on 
the eIF2/eIF5 complex, we carefully measured the abundance of total 
eIF2/eIF5 complex and the proportion of TC/eIF5 complex therein. 
However, we did not observe a dramatic change in the abundance of 
the eIF2/eIF5 complex free of tRNAiMet that would simply explain the 
marked difference in TC level (Fig. 5). Instead, we found that most of 
the eIF5/eIF3 complex was bound to eIF1 in the SC medium (Fig. 5C). 
Moreover, our studies suggest that the TC level increased during 
growth in SC medium while free eIF2 (likely GDP-bound) decreased 
when compared with YPD-grown cells (Fig. 5). Thus, the activity of 
eIF2B in producing eIF2·GTP and hence TC appears to be higher (or 
less limiting) in SC medium. The accumulation of an eIF1/eIF3/eIF5 
complex in SC medium (Fig. 5C) suggests that translation initiation is 
instead suppressed at the level of preinitiation complex function. This 
could include MFC interactions, mRNA binding and/or scanning. 
A mechanism to explain such regulation postulates that covalent 
modification controls eIF2B directly or indirectly by regulating the 
inhibitory eIF2/eIF5 complex. A candidate for the effector kinase of 
this regulation would be casein kinase 2 (CK2) that phosphorylates 
eIF2 in yeast 39, eIF2B in mammals 40, and eIF5 in both yeast and 
mammals 41; 42. If eIF2/eIF5 interaction is enhanced by 
phosphorylation to promote MFC formation in the YPD medium, the 
same modification could increase the stability of the inhibitory 
eIF2/eIF5 complex, thereby suppressing the TC abundance. While it is 
still unclear whether CK2 activity is regulated 43, yeast CK2 activity is 
regulated in a cell cycle-dependent manner, and activated at G1 and 
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G2/M phases 44. In humans, CK2-depependent PML protein 
degradation is regulated by a MAP kinase 45. Alternatively, control by 
one or more phosphatases might be critical for the postulated TC 
abundance regulation. It would be interesting to find out if this 
regulation via eIF2B or eIF2/eIF5 complex is downstream of the TOR 
kinases 36, or relates to the recently identified Gcn2p-indendent 
pathway that regulates eIF2B and TC formation 46. Further work is 
needed to delineate the Gcn2p-independent pathway(s) that regulate 
cellular TC abundance and to determine whether the eIF2/eIF5 
complex is a component in this regulation. 
Materials and methods 
Plasmid construction 
Plasmids used in this study are listed in Table III. To produce 
the TIF34-FL* allele encoding C-terminally FLAG-tagged eIF3i, the DNA 
segment encoding the epitope-tagged TIF34 ORF was amplified by PCR 
using oligo 7 (to hybridize to 5′-end of TIF34 ORF) 47 and oligo TIF34-
FL 5′-CCC AAG GAT CCT TAC TTG TCATCG TCA TCC TTG TAA TCA TTA 
GCT TCT TGC ATG TGC TCT TTA GC-3′ (BamHI site and FLAG-coding 
region underlined), followed by digestion with EcoRI and BamHI. The 
resulting 0.3-kb fragment (3′ fourth of TIF34-FL ORF) was cloned into 
the same sites of YCpL-TIF34-Bm 47 to produce YCpTIF34-FL. The 
0.5-kb EcoRI-HindIII fragment (3′ fourth of TIF34-FL ORF and its 3′ 
UTR) of YCpTIF34-FL was cloned into the same sites of pT7-TIF34 47 
to create pT7-TIF34-FL. To prepare pET-FL-SUI3, the 1.4-kb NdeI-
HindIII fragment of YCpSUI3 (FL-SUI3) 8 was cloned into pET23a 
(Novagen). 
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Table III Plasmids employed in this study. 
The RPL25-FH (or RPL25-FL-His) allele encodes C-terminally 
FLAG- and polyhistidine-tagged form of Rpl25p 48. To create pET-
RPL25-FH, the DNA fragment carrying RPL25-FH was PCR amplified 
using oligos RPL25 FW 5′-GGG GCC ATA TGG CTC CAT CTG CTA AGG 
CTA CTG CC-3′ and RPL25-RV 5′-GCC CAA GCT TGG ATC CTT AAT GAT 
GAT GAT GAT GAT GGC C-3′ (NdeI and HindIII sites underlined) and 
pRPL25-FH 48 as template. Its 510-kb NdeI-HindIII fragment was 
cloned into pET23a (Novagen). 
Yeast strains 
Yeast strains encoding epitope-tagged eIFs as the sole source 
are listed in Table II. KAY487 was constructed by plasmid shuffling 
using transformants of KAY6 (tif34Δ p[URA3 TIF34]) (K. Asano) 
carrying YCpTIF34-FL, and 5-fluoroorotic acid as a drug to select 
against Ura+ strains 49. The strains used for eIF level determinations 
grew like the wild type strains at all the temperatures tested (18°, 
22°, 30°, and 37° C), indicating that the tagged alleles are at least 
functional in supporting exponential growth in YPD medium. 
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Yeast growth media 
YPD medium contained 1% (w/v) yeast extract (Difco), 2% 
(w/v) bacto peptone (Difco), and 2% (w/v) glucose 50. SC medium is 
a synthetic defined medium [0.145% (w/v) yeast nitrogen base w/o 
amino acid and ammonium sulfate (Difco), 0.5% (w/v) ammonium 
sulfate and 2% (w/v) glucose] supplemented with 0.009% (w/v) of 
each 20 amino acids, inositol and uracyl, 0.002% (w/v) adenine, and 
0.0009% para-aminobenzoic acid 50. The SC-ura medium is the same 
as SC but lacks uracil. 
Protein purification 
The recombinant forms of FLAG-tagged eIFs or Rpl25p were 
purified from BL21(DE3) transformants carrying the corresponding pET 
or pT7 derivative plasmids (Table III) using anti-FLAG affinity resin 
(Sigma), as described previously 23. Purification of FL-eIF1 was 
described previously and the presence of its N-terminal FLAG peptide 
sequence was confirmed by peptide sequencing, prior to the 
experiment shown in Fig. 2B and C51. Yeast eIF2B was purified from 
strain GP3685 as described previously 28. 
eIF level determination by epitope-tagging and 
immunoblotting 
Yeast strains were first grown in 5 ml of the desired medium 
overnight at 30 °C. The cells were diluted until A600 = 0.4 into 50 ml of 
the same medium, grown for 3-4 hours at 30 °C and then collected at 
A600 = 1.5-2.0. Approximately 300-400 μg wet weight of cells were 
collected, washed, and resuspended in 250 μl buffer A containing 20 
mM Tris-HCl (pH 7.5), 100 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 7 mM 
β-mercaptoethanol, 5 mM NaF, 1 mM PMSF, Complete™ protease 
inhibitors (Roche), and 1 μg/mL each of pepstain A, leupeptin, and 
aprotinin. Resuspended cells were lysed by vortexing with 0.4 g of 0.5 
mm glass beads (3 cycles of 30-second vortexing and 30-second 
cooling on ice) and cleared by microcentrifugation for 15 mins at 
14000 rpm at 4° C. The recovered supernatants were employed as 
WCE. The protein concentration of WCE was measured by Bradford 
assay (BioRad Protein Assay kit I). 1.25 to 80 μg of total proteins for 
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each sample were incubated at 65 °C for 2 mins with Laemmli buffer 
[125mM Tris-HCL (pH 6.8), 4% SDS, 25% glycerol, 0.01% 
Bromophenol blue] and resolved by 10-20% Tris-Glycine gradient or 
7.5% or 12 % uniform gels. The proteins were transferred in Tris-
glycine transfer buffer for 4-5 hours onto Hybond ECL nitrocellulose 
membranes, the immobilized samples were incubated for 1 hour in 
PBS + T (PBS + 1% Tween-20) containing 5% non-fat dry milk. The 
blots were washed once for 15 minutes and twice for 5 minutes in 
PBS+T, and then incubated for 1 hour in PBS+T with mouse 
monoclonal anti-HA (diluted 1:2000) or anti-FLAG (diluted 1:500) or 
with rabbit polyclonal anti-eIF antibodies. After that, the blots were 
directly incubated with horseradish peroxidase-coupled secondary 
antibody to mouse or rabbit for 1 hour. Finally the blots were washed 
again, and the bands were visualized using the ECL chemiluminescent 
system (Amersham Pharmacia), followed by quantification using the 
NIHImage software. 
In the case of Rpl25p and eIF4G2, the antibodies raised against 
these proteins were not available. However, the expression of Rpl25-
FL is most likely equivalent to the endogenous Rpl25p, because (i) the 
protein was expressed from the natural promoter, (ii) Rpl25-FL 
precipitated >90% of yeast ribosomes by anti-FLAG affinity resin 
without altering its ribosomal protein composition 48 and (iii) no 
Rpl25-FL was found free of the ribosome, based on analyses of the 
supernatant fractions of the immunoprecipitation reaction or sucrose 
gradient polysome fractions of whole cell extracts (WCE) derived from 
YIT613 (T. Inada, personal communications). 
Determination of TC and other eIF complex levels in 
vivo 
WCE was prepared from FL-eIF2βor eIF5-FL strains, as 
described above. The scale of culture for WCE preparation was usually 
100 ml. 1 mg total protein of WCE was employed for 
immunoprecipitation with anti-FLAG antibodies in 200 μl of the buffer 
A containing RNasin (Promega), as described previously 5, except that 
the precipitated proteins on the anti-FLAG affinity resin were washed 
in the presence of 50 μM GMPPNP, the nonhydrolyzable GTP analogue. 
80 % of the precipitated fraction was used to quantify the amount of 
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tRNAiMet in the fraction by a standard protocol 52 with slight 
modifications: The RNA sample was extracted with citric acid-saturated 
phenol/chloroform/isoamyl alcohol (25:24:1) (pH4.3) (Fisher), 
precipitated with 3 volume ethanol, 1/10 volume of 3 M sodium 
acetate, and 20 μg of glycogen, and analyzed with purified tRNAiMet as 
the standard by 8 % urea PAGE, followed by electro-transfer to 
Hybond-XL membrane (Amersham Biosciences) in TBE buffer at 19 V 
for 60 min at 4°C, and northern blotting with the 5′-[32P] labeled oligo 
probe JA76 5′-AGC CCT GCG CGC TTC CAC TG-3′ specific for tRNAiMet. 
The hybridization was done in (0.5 M sodium phosphate, pH7.2, 7% 
SDS, and 10 mM EDTA) at 57°C for 20 hr. The membrane was then 
washed in 2 X SSPE containing 0.1 % SDS twice, then 1 X SSPE 
containing 0.1 % SDS twice, exposed to imaging plate for an 
appropriate time, and analyzed by Cyclone™ Storage Phosphor System 
(Packard). The reminder of the immunoprecipitated fraction was 
analyzed with purified eIF2 (a gift of E. Hannig) as the standard by 
SDS-PAGE followed by immunoblotting, as described above. 
Molar amounts of tRNAiMet and eIF2 precipitated were 
determined directly by comparing the band density against those of 
purified components. Molar amounts of other eIFs precipitated were 
determined based on the percentage of eIF precipitated and the level 
of the corresponding eIFs relative to eIF2. These values are presented 
below each gel in Fig. 1A. 
Quantitation of aminoacylated tRNAiMet 
To measure the relative amount of aminoacylated and 
deacylated tRNAiMet in our WCE sample, total RNA was isolated from 
WCE by adding them to 4.0 ml AE buffer (0.3 M NaOAc pH 4.5, 10 mM 
EDTA), followed by extraction with an equal volume of AE buffer-
saturated phenol by three rounds of vortex agitation for 1 min with a 1 
min incubation on ice between rounds of vortex agitation. After 
centrifugation at 3000xg for 15 min at 4°C, the aqueous portion of the 
sample was re-extracted by the addition of an equal volume of AE 
buffer-saturated phenol and vortex agitation as mentioned above. 
After a second centrifugation, the aqueous layer was collected. 
precipitated with 3 volume of ethanol and 1/10 volume of 3M sodium 
acetate, washed with 70% ethanol and resuspended in a buffer of 10 
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mM sodium acetate (pH 4.5) and 1 mM EDTA. Total tRNA sample 
containing intact aminoacyl tRNAs was purified in parallel from whole 
cells by suspending them directly into 4.0 ml of AE buffer, followed by 
phenol extraction and ethanol precipitation. The RNA samples were 
separated on a 6.5% acid-urea acrylamide gel exactly as described 26 
and transferred to Biodyne B membrane (Pall), followed by 
hybridization with radiolabeled probe JA11 (5′-
TCGGTTTCGATCCGAGGACATCAGGGTTATGA-3′) and phosphorimage 
analysis using a Storm 840 (GEhealthcare) as previously described 53. 
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Abbreviations 
 eIF        : eukaryotic initiation factor 
 TC         :  ternary complex 
GAP        : GTPase activating protein 
G protein : guanine nucleotide binding protein 
GEF         : guanine nucleotide exchange factor 
CTD        : carboxyl-terminal domain 
NTD        : amino-terminal domain 
YPD        : yeast-extract peptone dextrose (medium) 
SC          : synthetic defined complete (medium) 
MFC        : multifactor complex 
AA-box   : acidic and aromatic amino acid box 
PBS        : phosphate-buffered saline 
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GST       : glutathione S-transferase 
FH        : FLAG-epitope and polyhistidine double affinity tag 
WCE     : whole cell extracts 
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*To indicate the position of epitope-tag introduced, we named the 
tagged protein or allele by hyphenating the protein or gene name and 
the tag (preceded by a number indicating the tag's copy number) in 
the amino- to carboxyl- or 5′- to 3′- orientation, respectively. The 
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(DYKDDDDK) and HA for the influenza hemaglutinin peptide 
(YPYDVPDYA). Hexahistidine-tag (His) was fused for one-step affinity 
purification. 
References 
1. Pestova TV, Lorsch JR, Hellen CUT. The mechanism of translation 
initiation in eukaryotes. In: Mathews MB, Sonenberg N, Hershey 
JWB, editors. Translational Control in Biology and Medicine. Cold 
Spring Harbor Lab Press; Cold Spring Harbor, NY: 2007. pp. 87–
128. 
2. Hinnebusch AG, Dever TE, Asano K. Mechanism of translation 
initiation in the yeast Saccharomyces cerevisiae. In: Mathews 
MB, Sonenberg N, Hershey JWB, editors. Translational Control in 
Biology and Medicine. Cold Spring Harbor Lab Press; Cold Spring 
Harbor, NY: 2007. pp. 225–268. 
3. Huang H, Yoon H, Hannig EM, Donahue TF. GTP hydrolysis controls 
stringent selection of the AUG start codon during translation 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
36 
 
initiation in Saccharomyces cerevisiae. Genes Dev. 
1997;11:2396–2413.  
4. Algire MA, Maag D, Lorsch JR. Pi release from eIF2, not GTP 
hydrolysis, is the step controlled by start-site selection during 
eukaryotic translation initiation. Mol Cell. 2005;20:1–12.  
5. Asano K, Clayton J, Shalev A, Hinnebusch AG. A multifactor complex 
of eukaryotic initiation factors eIF1, eIF2, eIF3, eIF5, and 
initiator tRNAMet is an important translation initiation 
intermediate in vivo. Genes Dev. 2000;14:2534–2546 
6. Yamamoto Y, Singh CR, Marintchev A, Hall NS, Hannig EM, Wagner 
G, Asano K. The eukaryotic initiation factor (eIF) 5 HEAT domain 
mediates multifactor assembly and scanning with distinct 
interfaces to eIF1, eIF2, eIF3 and eIF4G. Proc Natl Acad Sci 
USA. 2005;102:16164–16169.  
7. Wei Z, Xue Y, Xu H, Gong W. Crystal structure of the C-terminal 
domain of S. cerevisiae eIF5. J Mol Biol. 2006;359:1–9.  
8. Asano K, Krishnamoorthy T, Phan L, Pavitt GD, Hinnebusch AG. 
Conserved bipartite motifs in yeast eIF5 and eIF2Bε, GTPase-
activating and GDP-GTP exchange factors in translation 
initiation, mediate binding to their common substrate eIF2. 
EMBO J. 1999;18:1673–1688.  
9. Pavitt GD, Ramaiah KVA, Kimball SR, Hinnebusch AG. eIF2 
independently binds two distinct eIF2B subcomplexes that 
catalyze and regulate guanine-nucleotide exchange. Genes Dev. 
1998;12:514–526.  
10. Gomez E, Mohammad SS, Pavitt GP. Characterization of the 
minimal catalytic domain within eIF2B: the guanine-nucleotide 
exchange factor for translation initiation. EMBO Journal. 
2002;21:5292–5301.  
11. Alone PV, Dever TE. Direct binding of translation initiation factor 
eIF2gamma-G domain to its GTPase-activating and GDP-GTP 
exchange fctors eIF5 and eIF2Beplsilon. J Biol Chem. 
2006;281:12636–12644.  
12. Dever TE. Gene-specific regulation by general translation factors. 
Cell. 2002;108:545–556.  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
37 
 
13. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: 
effectors of mRNA recruitment to ribosomes and regulators of 
translation. Ann Rev Biochem. 1999;68:913–963.  
14. Futcher B, Latter GI, Monardo P, McLaughlin CS, Garrels JI. A 
sampling of the yeast proteome. Mol Cell Biol. 1999;19:7357–
7368.  
15. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, 
Dephoure N, O'Shea EK, Weissman JS. Global analysis of protein 
expression in yeast. Nature. 2003;425:737–741.  
16. von der Haar T, McCarthy JEG. Intracellular translation initiation 
factor levels in S. cerevisiae and their role in cap-complex 
formation. molecular microbiology. 2002;46:531–544.  
17. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, 
Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili 
A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, 
Yang M, Johnston M, Fields S, Rothberg JM. A comprehensive 
analysis of protein-protein intractions in Saccharomyces 
cerevisiae. Nature. 2000;403:623–627.  
18. Gavin AC, Aloy P, Grandi P, Krause R, Boesche M, Marzioch M, Rau 
C, Jensen LJ, Bastuck S, Dümpelfeld B, Edelmann A, Heurtier 
MA, Hoffman V, Hoefert C, Klein K, Hudak M, Michon AM, 
Schelder M, Schirle M, Remor M, Rudi T, Hooper S, Bauer A, 
Bouwmeester T, Casari G, Drewes G, Neubauer G, Rick JM, 
Kuster B, Bork P, Russell RB, Superti-Furga G. Proteome survey 
reveals modularity of the yeast cell machinery. Nature. 
2006;440:631–636.  
19. Krogan NJ, Cagney G, Yu H, Zhong G, Guo X, Ignatchenko A, Li J, 
Pu S, Datta N, Tikuisis AP, Punna T, Peregrin-Alvarez JM, Shales 
M, Zhang X, Davey M, Robinson MD, Paccanaro A, Bray JE, 
Sheung A, Beattie B, Richards DP, Canadien V, Lalev A, Mena F, 
Wong P, Starostine A, Canete MM, Vlasblom J, Wu S, Orsi C, 
Collins SR, Chandran S, Haw R, Rilstone JJ, Gandi K, Thompson 
NJ, Musso G, St Onge P, Ghanny S, Lam MH, Butland G, Altaf-Ul 
AM, Kanaya S, Shilatifard A, O'Shea E, Weissman JS, Ingles CJ, 
Hughes TR, Parkinson J, Gerstein M, Wodak SJ, Emili A, 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
38 
 
Greenblatt JF. Global landscape of protein complexes in the 
yeast Saccharomyces cerevisiae. Nature. 2006;440:637–643.  
20. Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, Fasolo J, Guo H, 
Jona G, Breitkreutz A, Sopko R, McCartney RR, Schmidt MC, 
Rachidi N, Lee SJ, Mah AS, Meng L, Stark MJ, Stern DF, De 
Virgilio C, Tyers M, Andrews B, Gerstein M, Schweitzer B, Predki 
PF, Snyder M. Global analysis of protein phosphorylation in 
yeast. Nature. 2005;438:679–684.  
21. Krogan NJ, Peng WT, Cagney G, Robinson MD, Haw R, Zhong G, 
Guo X, Zhang X, Canadien V, Richards DP, Beattie BK, Lalev A, 
Zhang W, Davierwala AP, Mnaimneh S, Starostine A, Tikuisis AP, 
Grigull J, Datta N, Bray JE, Hughes TR, Emili A, Greenblatt JF. 
High-definition macromoletular composition of yeast RNA-
processing complexes. Mol Cell. 2005;13:225–239.  
22. Singh CR, Lee B, Udagawa T, Mohammad-Quereshi SS, Yamamoto 
Y, Pavitt GD, Asano K. An eIF5/eIF2 complex antagonizes 
guanine nucleotide exchange by eIF2B during translation 
initiation. EMBO J. 2006;25:4537–4546.  
23. Asano K, Lon P, Krishnamoorthy T, Pavitt GD, G E, Hannig EM, 
Nika J, Donahue TF, Huang HK, Hinnebusch AG. Analysis and 
Reconstitution of Translation Initiation In Vitro. Methods in 
Enzymology. 2002;351:221–247.  
24. Warner JR. The economics of ribosome biosynthesis in yeast. 
Trends Biochem Sci. 1999;24:437–440.  
25. Singh CR, Curtis C, Yamamoto Y, Hall NS, Kruse DS, Hannig EM, 
Asano K. eIF5 is critical for the integrity of the scanning 
preinitiation complex and accurate control of GCN4 translation. 
Molecular and Cellular Biology. 2005;25:5480–5491.  
26. Varshney U, Lee CP, RajBhandary UL. Direct Analysis of 
Aminoacylation Levels of tRNAs in Vivo. Application to studying 
recognition of Escherichia coli initiator tRNA mutants by 
glutaminyl-tRNA synthetase. J Biol Chem. 1991;266:24712–
24718.  
27. Pavitt GD, Yang W, Hinnebusch AG. Homologous segments in three 
subunits of the guanine nucleotide exchange factor eIF2B 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
39 
 
mediate translational regulation by phosphorylation of eIF2. Mol 
Cell Biol. 1997;17:1298–1313.  
28. Richardson JP, Mohammad SS, Pavitt GD. Mutations causing 
childhood ataxia with central nervous system hypomyelination 
reduce eukaryotic initiation factor 2B complex formation and 
activity. Mol Cell Biol. 2004;24:2352–2363. 29. Hinnebusch AG. 
Mechanism and regulation of initiator methionyl-tRNA binding to 
ribosomes. In: Sonenberg N, Hershey JWB, Mathews MB, 
editors. Translational Control of Gene Expression. Cold Spring 
Harbor Laboratory Press; Cold Spring Harbor: 2000. pp. 185–
243. 
30. Singh CR, Yamamoto Y, Asano K. Physical association of eukaryotic 
initiation factor 5 (eIF5) carboxyl terminal domain with the 
lysine-rich eIF2β segment strongly enhances its binding to eIF3. 
Journal of Biological Chemistry. 2004;279:49644–49655.  
31. Dever TE, Feng L, Wek RC, Cigan AM, Donahue TD, Hinnebusch 
AG. Phosphorylation of initiation factor 2α by protein kinase 
GCN2 mediates gene-specific translational control of GCN4 in 
yeast. Cell. 1992;68:585–596.  
32. Campbell SG, Hoyle NP, Ashe MP. Dynamic cycling of eIF2 through 
a large eIF2B-containing cytoplasmic body: implications for 
translational control. J Cell Biol. 2005;170:925–934 
33. Fekete CA, Applefield DJ, Blakely SA, Shirokikh N, Pestova T, 
Lorsch JR, Hinnebusch AG. The eIF1A C-terminal domain 
promotes initiation complex assembly, scanning and AUG 
selection in vivo. EMBO J. 2005;24:3588–3601 
34. Newman JR, Ghaemmaghami S, Ihmels J, Breslow DK, Noble M, 
DeRisi JL, Weissman JS. Single-cell proteomic analysis of S. 
cerevisiae reveals the architecture of biological noise. Nature. 
2006;441:840–846.  
35. Dong J, Qiu H, Garcia-Barrio M, Anderson J, Hinnebusch AG. 
Uncharged tRNA activates GCN2 by displacing the protein kinase 
moiety from a bipartite tRNA-binding domain. Mol Cell. 
2000;6:269–279.  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
40 
 
36. Powers T. Ribosome biogenesis: giant steps for a giant problem. 
Cell. 2004;119:901–902.  
37. Cherkasova VA, Hinnebusch AG. Translational control by TOR and 
TAP42 through dephosphorylation of eIF2 kinase GCN2. Genes 
and Development. 2003;17:859–872.  
38. Rutter J, Probst BL, McKnight SL. Coordinate reulgation of sugar 
flux and translatiion by PAS kinase. Cell. 2002;111:17–28.  
39. Feng L, Yoon H, Donahue TF. Casein kinase II mediates multiple 
phosphorylation of Saccharomyces cerevisiae eIF-2α (encoded 
by SUI2), which is required for optimal eIF-2 function in S. 
cerevisiae. Mol Cell Biol. 1994;14:5139–5153.  
40. Wang X, Paulin FEM, Campbell LE, Gomez E, O'Brien K, Morrice N, 
Proud CG. Eukaryotic initiation factor 2B: identification of 
multiple phosphorylation sites in the e-subunit and their 
functions in vivo. EMBO J. 2001;20:4349–4359. 
41. Maiti T, Bandyopadhyay A, Maitra U. Casein kinase II 
phosphorylates translation initiation factor 5 (eIF5) in 
Saccharomyces cerevisiae. Yeast. 2003;20:97–108.  
42. Homma MK, Wada I, Suzuki T, Yamaki J, Krebs EG, Homma Y. CK2 
phosphorylation of eukaryotic translation initiation factor 5 
potentiates cell cylce progression. Proc Acad Natl Sci USA. 
2005;102:15688–15693.  
43. Litchfield DW. Protein kinase CK2: structure, regulation and role in 
cellular decsions of life and death. Biochem J. 2003;369:1–15.  
44. Hanna DE, Rethinaswamy A, Glover CVC. Casein kinase II is 
required for cell cycle progression during G1 and G2/M in 
Saccharomyces cerevisiae. J Biol Chem. 1995;270:25905–
25914.  
45. Scaglioni PP, Young TM, Cai LF, Erdjument-Bromage H, Kaufman 
AJ, Singh B, Teruya-Feldstein J, Tempst P, Pandolfi PP. A CK2-
depndent mechanism for degradtion of the PML tumor 
suppressor. Cell. 2006;126:269–283.  
46. Smirnova JB, Selley JN, Sanchez-Cabo F, Carroll K, Eddy AA, 
McCarthy JEG, Hubbard SJ, Pavitt GD, Grant CM, Ashe MP. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
41 
 
Global Gene Expression Profiling Reveals Widespread yet 
Distinctive Translational Responses to Different Eukaryotic 
Translation Initiation Factor 2B-Targeting Stress Pathways. Mol 
Cell Biol. 2005;25:9340–9349.  
47. Asano K, Phan L, Anderson J, Hinnebusch AG. Complex formation 
by all five homologues of mammalian translation initiation factor 
3 subunits from yeast Saccharomyces cerevisiae. J Biol Chem. 
1998;273:18573–18585.  
48. Inada T, Winstall E, Tarun SZ, Yates JR, Schieltz D, Sachs AB. 
One-step affinity purification of the yeast ribosome and its 
associted proteins and mRNAs. RNA. 2002;8:948–958.  
49. Boeke JD, Trueheart J, Natsoulis G, Fink GR. 5-fluoroorotic acid as 
a selective agent in yeast molecular genes. Methods Enzymol. 
1987;154:164–175. [PubMed] 
50. Sherman F. Getting started with yeast. Methods Enzymol. 
1991;191:3–21.  
51. Singh CR, Hui H, Ii M, Yamamoto Y, Asano K. Efficient 
incorporation of eIF1 into the multifactor complex is critical for 
formation of functional ribosomal preinitiation complexes in 
vivo. Journal of Biological Chemistry. 2004;279:31910–31920.  
52. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a 
Laboratory Manual. 2. Cold Spring Harbor Laboratory; Cold 
Spring Harbor, NY: 1989.  
53. Anderson J, Phan L, Cuesta R, Carlson BA, Pak M, Asano K, Bjork 
GR, Tamame M, Hinnebusch AG. The essential Gcd10p-Gcd14p 
nuclear complex is required for 1-methyladenosine modification 
and maturation of initiator methionyl-tRNA. Genes and 
Development. 1998;12:3650–3662.  
54. Asano K, Shalev A, Phan L, Nielsen K, Clayton J, Valasek L, 
Donahue TF, Hinnebusch AG. Multiple roles for the carboxyl 
terminal domain of eIF5 in translation initiation complex 
assembly and GTPase activation. EMBO Journal. 2001;20:2326–
2337.  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
42 
 
55. Tarun SZ, Sachs AB. Binding of eukaryotic translation initiation 
factor 4E (eIF4E) to eIF4G represses translation of uncapped 
mRNA. Molecular and Cellular Biology. 1997;17:6876–6886.  
56. Ramirez M, Wek RC, Vazquez de Aldana CR, Jackson BM, Freeman 
B, Hinnebusch AG. Mutations activating the yeast eIF-2α kinase 
GCN2: Isolation of alleles altering the domain related to histidyl-
tRNA synthetases. Mol Cell Biol. 1992;12:5801–5815.  
 
About the Authors 
Katsura Asano: kasano@ksu.edu 
  
